Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials

Título

Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials

Autor

Rami A. Al-Horani, Srabani Kar, Kholoud F. Aliter

Descripción

The ongoing pandemic of coronavirus disease-2019 (COVID-19) is being caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The disease continues to present significant challenges to the health care systems around the world. This is primarily because of the lack of vaccines to protect against the infection and the lack of highly effective therapeutics to prevent and/or treat the illness. Nevertheless, researchers have swiftly responded to the pandemic by advancing old and new potential therapeutics into clinical trials. In this review, we summarize potential anti-COVID-19 therapeutics that block the early stage of the viral life cycle. The review presents the structures, mechanisms, and reported results of clinical trials of potential therapeutics that have been listed in clinicaltrials.gov. Given the fact that some of these therapeutics are multi-acting molecules, other relevant mechanisms will also be described. The reviewed therapeutics include small molecules and macromolecules of sulfated polysaccharides, polypeptides, and monoclonal antibodies. The potential therapeutics target viral and/or host proteins or processes that facilitate the early stage of the viral infection. Frequent targets are the viral spike protein, the host angiotensin converting enzyme 2, the host transmembrane protease serine 2, and clathrin-mediated endocytosis process. Overall, the review aims at presenting update-to-date details, so as to enhance awareness of potential therapeutics, and thus, to catalyze their appropriate use in combating the pandemic.

Fecha

2020

Materia

coronavirus, covid-19, SARS-CoV-2, ACE2, viral entry, viral fusion

Identificador

10.3390/ijms21155224

Fuente

Epidemiology and Health

Editor

Korean Society of Epidemiology

Cobertura

Biology (General), Chemistry

Archivos

https://socictopen.socict.org/files/to_import/pdfs/478bc91e3e6479e792c838116286e56d.pdf

Colección

Citación

Rami A. Al-Horani, Srabani Kar, Kholoud F. Aliter, “Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials,” SOCICT Open, consulta 18 de abril de 2026, https://socictopen.socict.org/items/show/4740.

Formatos de Salida

Position: 17836 (17 views)